Dupilumab: a novel treatment for asthma

References

• WenzelSEComplex phenotypes in asthma: current definitionsPulm Pharmacol Ther201326671071523880027
   PubMed Web of Science ®Google Scholar
• MurdochJRLloydCMChronic inflammation and asthmaMutat Res20106901–2243919769993
   PubMed Web of Science ®Google Scholar
• HoltPGSlyPDInteraction between adaptive and innate immune pathways in the pathogenesis of atopic asthma: operation of a lung/bone marrow axisChest201113951165117121540215
   PubMed Web of Science ®Google Scholar
• HammadHChieppaMPerrosFHouse dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cellsNat Med200915441041619330007
   PubMed Web of Science ®Google Scholar
• WoodruffPGModrekBChoyDFT-helper type 2-driven inflammation defines major sub-phenotypes of asthmaAm J Respir Crit Care Med2009180538839519483109
   PubMed Web of Science ®Google Scholar
• LiuYJThymic stromal lymphopoietin: master switch for allergic inflammationJ Exp Med2006203226927316432252
   PubMed Web of Science ®Google Scholar
• LarchéMRobinsonDSKayABThe role of T lymphocytes in the pathogenesis of asthmaJ Allergy Clin Immunol2003111345046312642820
   PubMed Web of Science ®Google Scholar
• FulkersonPCRothenbergMETargeting eosinophils in allergy, inflammation and beyondNat Rev Drug Discov201312211712923334207
   PubMed Web of Science ®Google Scholar
• BarnesPJThe cytokine network in asthma and chronic obstructive pulmonary diseaseJ Clin Invest2008118113546355618982161
   PubMed Web of Science ®Google Scholar
• KaikoGEFosterPSNew insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthmaCurr Opin Allergy Clin Immunol2011111394521150435
   PubMed Web of Science ®Google Scholar
• ScanionSTMcKenzieANJType 2 innate lymphoid cells: new players in asthma and allergyCurr Opin Immunol201224670771222985480
   PubMed Web of Science ®Google Scholar
• HalimTYMcKenzieANNew kids on the block – group 2 innate lymphoid cells and type 2 inflammation in the lungChest201314451681168624189861
   PubMed Web of Science ®Google Scholar
• SteinkeJWBorishLTh2 cytokines and asthma. Interleukin 4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonistsRespir Res200122667011686867
   PubMed Web of Science ®Google Scholar
• CorrenJRole of interleukin-13 in asthmaCurr Allergy Asthma Rep201313541542024026573
   PubMed Web of Science ®Google Scholar
• OhCKGebaGPMolfinoNInvestigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthmaEur Respir Rev201019115465420956165
   PubMedGoogle Scholar
• AndrewsRRosaLDainesMKhuranaHGReconstitution of a functional human type II IL-4/IL-13 in mouse B cells: demonstration of species specificityJ Immunol200116631716172211160216
   PubMed Web of Science ®Google Scholar
• ChibaYGotoKMisawaMInterleukin-13-induced activation of signal transducer and activator of transcription 6 is mediated by an activation of Janus kinase 1 in cultured human bronchial smooth muscle cellsPharmacol Rep201264245445822661199
   PubMed Web of Science ®Google Scholar
• ZhengTLiuWOhSYIL-13 receptor α2 selectively inhibits IL-13-induced responses in the murine lungJ Immunol2008180152252918097054
   PubMed Web of Science ®Google Scholar
• MaesTJoosGFBrusselleGGTargeting IL-4 in asthma: lost in translation?Am J Respir Cell Mol Biol201247326127022538865
   PubMed Web of Science ®Google Scholar
• SahaSKBerryMAParkerDIncreased sputum and bronchial biopsy IL-13 expression in severe asthmaJ Allergy Clin Immunol2008121368569118328894
   PubMed Web of Science ®Google Scholar
• CorrenJAnti-interleukin-13 antibody therapy for asthma: one step closerEur Respir J201341225525623370798
   PubMed Web of Science ®Google Scholar
• PrietoJLensmarCRoquetAIIncreased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocationsRespir Med200094880681410955758
   PubMed Web of Science ®Google Scholar
• HowardTDKoppelmanGHXuJGene-gene interaction in asthma: IL4RA and IL-13 in a Dutch population with asthmaAm J Hum Genet200270123023611709756
   PubMed Web of Science ®Google Scholar
• LiXHowardTDZhengSLGenome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regionsJ Allergy Clin Immunol2010125232833520159242
   PubMed Web of Science ®Google Scholar
• GrunigGWarnockMWakilAERequirement for IL-13 independently of IL-4 in experimental asthmaScience19982825397226122639856950
   PubMed Web of Science ®Google Scholar
• Wills-KarpMLuyimbaziJXuXInterleukin-13: central mediator of allergic asthmaScience19982825397225822619856949
   PubMed Web of Science ®Google Scholar
• MunitzABrandtEBMinglerMDistinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesisProc Natl Acad Sci U S A2008105207240724518480254
   PubMed Web of Science ®Google Scholar
• KotsimbosTCErnstPHamidQAInterleukin-13 and interleukin-4 are coexpressed in atopic asthmaProc Assoc Am Physicians199610853683738902881
   PubMedGoogle Scholar
• CoyleAJLe GrosGBertrandCInterleukin-4 is required for the induction of lung Th2 mucosal immunityAm J Respir Cell Mol Biol199513154597598937
   PubMed Web of Science ®Google Scholar
• SwartDAAnders-BartholoPMTockerJEEffects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in miceJ Allergy Clin Immunol20081212S267
   PubMed Web of Science ®Google Scholar
• PelaiaGVatrellaAMaselliRThe potential of biologics for the treatment of asthmaNat Rev Drug Discov2012111295897223197041
   PubMed Web of Science ®Google Scholar
• SteinkeJWAnti-interleukin-4 therapyImmunol Allergy Clin North Am200424459961415474861
   PubMed Web of Science ®Google Scholar
• Burmeister GetzEFisherDMFullerRHuman pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthmaJ Clin Pharmacol20094991025103619717725
   PubMed Web of Science ®Google Scholar
• HolgateSTPathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches?J Allergy Clini Immunol20111283495505
   Web of Science ®Google Scholar
• WenzelSWilbrahamDFullerREffect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studiesLancet200737095961422143117950857
   PubMed Web of Science ®Google Scholar
• SlagerREOtulanaBAHawkinsGAIL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonistJ Allergy Clin Immunol2012130251652222541248
   PubMed Web of Science ®Google Scholar
• YangGVolkAPetleyTAnti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodelingCytokine200428622423215566951
   PubMed Web of Science ®Google Scholar
• BlanchardCMishraASaito-HakeiHInhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human interleukin-13 antibody (CAT-354)Clin Exp Allergy20053581096110316120093
   PubMed Web of Science ®Google Scholar
• PiperEBrightlingCNivenRA phase II placebo-controlled study of tralokinumab in moderate-to-severe asthmaEur Respir J201341233033822743678
   PubMed Web of Science ®Google Scholar
• GauvreauGMBouletLPCockroftDWEffects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthmaAm J Respir Crit Care Med201118381007101421057005
   PubMed Web of Science ®Google Scholar
• ThomsonNCPatelMSmithADLebrikizumab in the personalized management of asthmaBiologics2012632933523055690
   PubMedGoogle Scholar
• YuyamaNDaviesDEAkaiwaMAnalysis of novel disease-related genes in bronchial asthmaCytokine200219628729612421571
   PubMed Web of Science ®Google Scholar
• TakayamaGArimaKKanajiTPeriostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signalsJ Allergy Clin Immunol200611819810416815144
   PubMed Web of Science ®Google Scholar
• JiaGEricksonRWChoyDFPeriostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patientsJ Allergy Clin Immunol2012130364765422857879
   PubMed Web of Science ®Google Scholar
• CorrenJLemanskeRFHananiaNALebrikizumab treatment in adults with asthmaN Engl J Med2011365121088109821812663
   PubMed Web of Science ®Google Scholar
• NoonanMKorenblatPMosesovaSDose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroidsJ Allergy Clin Immunol2013132356757423726041
   PubMed Web of Science ®Google Scholar
• De BoeverEHAshmanCCahnAPEfficacy and safety of an anti-IL-13 mAB in patients with severe asthma: a randomized trialJ Allergy Clin Immunol2014133498999624582316
   PubMed Web of Science ®Google Scholar
• WenzelSFordLPearlmanDDupilumab in persistent asthma with elevated eosinophil levelsN Engl J Med2013368262455246623688323
   PubMed Web of Science ®Google Scholar
• WechslerMEInhibiting IL-4 and IL-13 in difficult-to-control asthmaN Engl J Med2013368262511251323688322
   PubMed Web of Science ®Google Scholar
• GallelliLBuscetiMTVatrellaAMaselliRPelaiaGUpdate on anti-cytokine treatment for asthmaBiomed Res Int2013201310431523853765
   PubMed Web of Science ®Google Scholar